Bottom line
Is EWL a good fund? The bottom line
EWL is an index large blend ETF from iShares.
It charges 0.5% — about $50 a year on every $10,000 invested, cheaper than 77% of large blend funds we track.
It returned −2.6% over one year, +4.6% a year over five years, +6.0% a year over ten (as of Dec 31, 2024, per its prospectus).
With $1.7 billion in net assets and 46 holdings, its largest position is Roche Holding AG (14.0%) and the top 10 make up 67% of the portfolio.
What stands out
- Low cost: cheaper than 77% of large blend peers
What to watch
- 5-year return in the bottom quarter of its category
- Concentrated: top 10 holdings are 67% of assets
Updated Nov 19, 2026
What EWL invests in
The iShares MSCI Switzerland ETF (the Fund ) seeks to track the investment results of an index composed of Swiss equities.
The Fund seeks to track the investment results of the MSCI Switzerland 25/50 Index (the Underlying Index ), which is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large- and mid-capitalization segments of the equity market in Switzerland. The Underlying Index is rebalanced quarterly using an optimization process that aims to minimize the constituent weight differences between the Underlying Index and the MSCI Switzerland Index (the Parent Index ). The Underlying Index uses a capping methodology that limits the weight of any single group entity (constituents that MSCI determines have a control relationship) to a maximum of 25% of the Underlying Index weight, and the sum of all group entities with a weight above 5% to an aggregate of 50% of the Underlying Index weight. A group entity is a group of companies that operate as…
From the fund's prospectus (filed Dec 30, 2025).
EWL performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| EWL | −2.6% | +4.6% | +6.0% |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2024
What EWL costs
On a $10,000 investment, EWL's 0.5% expense ratio costs about $50 a year. The prospectus estimates $628 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
EWL top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Roche Holding AG | 14.03% |
| 2 | Novartis AG | 13.56% |
| 3 | Nestle S.A. | 12.34% |
| 4 | ABB Ltd | 5.41% |
| 5 | UBS Group AG | 5.13% |
| 6 | Compagnie Financiere Richemont Sa | 4.78% |
| 7 | Zurich Insurance Group AG | 4.44% |
| 8 | Holcim AG | 2.64% |
| 9 | Lonza Group AG | 2.35% |
| 10 | Swiss Re AG | 2.32% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 67% of the fund. See all top 25 holdings and asset mix →